- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
DDI2 Antibody / DNA Damage Inducible 1 Homolog 2 Antibody recognizes a ubiquitin-associated aspartyl protease involved in protein quality control and cellular responses to proteasome dysfunction. The DDI2 gene encodes DNA damage inducible 1 homolog 2, also known as protein DDI1 homolog 2, a member of a conserved family of proteins containing retroviral protease-like domains. DDI2 participates in the processing of ubiquitinated proteins and contributes to mechanisms that maintain intracellular protein homeostasis under conditions of proteotoxic stress.
One of the best-characterized functions of DDI2 is its role in activating nuclear factor erythroid 2-related factor 1 (NFE2L1), also called NRF1. This transcription factor regulates the expression of proteasome subunit genes and helps restore proteasome capacity when protein degradation becomes impaired. Under normal conditions, NRF1 is associated with the endoplasmic reticulum and undergoes continuous processing and degradation. When proteasome activity is inhibited, NRF1 escapes efficient degradation and becomes a substrate for DDI2-mediated proteolytic cleavage. The processed transcription factor can then enter the nucleus and stimulate proteasome gene expression.
DDI2 contains a conserved aspartyl protease domain and regions involved in interactions with ubiquitinated proteins. Biochemical studies have demonstrated that DDI2 preferentially cleaves certain highly polyubiquitinated substrates, supporting its classification as a ubiquitin-directed endoprotease. This activity distinguishes DDI2 from conventional deubiquitinating enzymes, which remove ubiquitin modifications rather than cleaving the modified protein itself. Through its effects on NRF1, DDI2 contributes to the adaptive response often described as proteasome recovery or the proteasome bounce-back response.
DDI2 has attracted attention in cancer research because its activity can influence cellular resistance to proteasome inhibitors. Experimental studies have shown that disrupting DDI2-dependent NRF1 activation can increase sensitivity to proteasome inhibition in certain cancer models. DDI2 has also been implicated in responses to replication stress, connecting its biological functions with genome maintenance and cellular survival. NSJ Bioreagents offers this DDI2 Antibody for investigating ubiquitin-dependent proteolysis, proteasome regulation, and the molecular mechanisms that allow cells to adapt to impaired protein degradation.
Explore related research targets in our Cell Biology Antibodies collection.
Users should optimize the working dilution of the DDI2 Antibody / DNA Damage Inducible 1 Homolog 2 Antibody for their specific experimental setup.
The DDI2 Antibody was generated using e. coli-derived human DNA Damage Inducible 1 Homolog 2 recombinant protein (amino acids Q46-P399).
Once reconstituted, refrigerate the DDI2 Antibody at 4oC for no longer than one month. For extended storage, freeze aliquots at -20oC for up to six months and avoid repeated freeze-thaw cycles.
Protein DDI1 homolog 2 antibody, DNA damage inducible 1 homolog 2 antibody, DDI1-like protein 2 antibody, Ubiquitin-directed endoprotease DDI2 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.